900917 Stock Overview
Engages in the pharmaceutical, textile and clothing, and finance businesses.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Shanghai Haixin Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.20 |
| 52 Week High | CN¥0.35 |
| 52 Week Low | CN¥0.17 |
| Beta | 0.46 |
| 11 Month Change | 3.55% |
| 3 Month Change | -30.85% |
| 1 Year Change | -23.31% |
| 33 Year Change | -41.21% |
| 5 Year Change | -52.67% |
| Change since IPO | 34.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 900917 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.6% | -3.1% | -1.4% |
| 1Y | -23.3% | -17.7% | -19.1% |
Return vs Industry: 900917 underperformed the CN Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: 900917 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
| 900917 volatility | |
|---|---|
| 900917 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 900917's share price has been volatile over the past 3 months.
Volatility Over Time: 900917's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 760 | n/a | www.haixin.com.cn |
Shanghai Haixin Group Co., Ltd. engages in the pharmaceutical, textile and clothing, and finance businesses. It is also involved in the industrial park business. The company was founded in 1986 and is based in Shanghai, China.
Shanghai Haixin Group Co., Ltd. Fundamentals Summary
| 900917 fundamental statistics | |
|---|---|
| Market cap | US$573.24m |
| Earnings (TTM) | US$23.63m |
| Revenue (TTM) | US$152.60m |
33.0x
P/E Ratio5.1x
P/S RatioIs 900917 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 900917 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.11b |
| Cost of Revenue | CN¥583.39m |
| Gross Profit | CN¥525.33m |
| Other Expenses | CN¥353.63m |
| Earnings | CN¥171.70m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 24, 2024
| Earnings per share (EPS) | 0.14 |
| Gross Margin | 47.38% |
| Net Profit Margin | 15.49% |
| Debt/Equity Ratio | 0.9% |
How did 900917 perform over the long term?
See historical performance and comparison